With other major players like Sun Pharma and Dr Reddy's also set to launch, the entry of Natco's ₹1,290 per month vial signals a significant shift in affordability.

Eris launch coincides with a parallel entry by Natco Pharma, which will also bring its semaglutide injections to market on the first day of patent expiry tomorrow ...

Novo Nordisk is expected to lose the patent in 10 more countries, including Brazil, China, South Africa, Turkey, and Canada, by the end of 2026.

General Hospital recaps for Thursday, March 19 reveal Carly Spencer (Laura Wright) officially broke up with Jack Brennan (Chris L. McKenna) while Jason Morgan (Steve Burton) got his sniper rifle.Plus, ...

On General Hospital on March 19, Marco got Britt's medication, L placed Lucas at risk, while Jason took action against Cullum ...

Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company, today announces that it has entered into an agreement with Cipla Limited and Cipla USA, Inc. to settle the ...

The PIS elicited a potent immune response as measured by local skin tests and immunological assays.

Glenmark Pharmaceuticals will launch Potassium Phosphates Injection USP, a bioequivalent to Fresenius Kabi's drug. The company will begin US distribution in March 2026, entering a market with annual ...

Glenmark Pharmaceuticals Inc USA is set to launch its bioequivalent Potassium Phosphates Injection USP in March 2026. The product, comparable to the Fresenius Kabi version, aims to capture a share of ...

It was just a homemade thing, when I look back I think I had no idea where it actually came from. I could have died.” Keeley said the syringes arrived in a non-branded wrapper enclosed with tissue and ...

From its 17-year development cycle through to its commercial launch, production has always been in Yeztugo’s DNA. | From its ...